Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas (vol 28, pg 677, 2022)

Funda Meric-Bernstam,Randy F. Sweis,F. Stephen Hodi,Wells A. Messersmith,Robert H. I. Andtbacka,Matthew Ingham,Nancy Lewis,Xinhui Chen,Marc Pelletier,Xueying Chen,Jincheng Wu,Thomas W. Dubensky,Sarah M. McWhirter,Thomas Mueller,Nitya Nair,Jason J. Luke

CLINICAL CANCER RESEARCH（2023）

引用 69|浏览6

暂无评分

摘要

In the original version of this article (1), author Thomas W. Dubensky is mistakenly omitted from the author list. This error has been corrected in the latest online HTML and PDF versions of the article and the author contributions and disclosures have been updated as necessary. The authors regret this error.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要